July 2, 2026 · Form 4 insider transaction
Tatsis Ourania sold 1,500 shares of Vertex Pharmaceuticals Incorporated at $524.99 per share, a transaction worth $787.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.